{"disease":{"id":"unresectable-recurrent-locally-advanced-or-metastatic-gastric-or-gastroesophageal-junction-adenocarcinoma","name":"unresectable recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02625623","title":"Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"EMD Serono Research & Development Institute, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}